Aberrant human epidermal growth factor receptor-2 (HER2) signaling is implicated in various solid tumors, including BC, GC, biliary tract cancer, CRC, OC, and PC, where HER2 overexpression or amplification promotes tumor growth, invasion, and is associated with poor prognosis (168). The gene discussed is ERBB2; the disease is breast cancer.